Advertisement

Leucovorin Calcium Injection

[23 July 2015]

Products Affected - Description

Leucovorin Calcium Lyophilized Powder for Injection, Fresenius Kabi
200 mg vial, 1 count (NDC 63323-0710-50)
500 mg vial, 1 count (NDC 63323-0711-00)
 
Leucovorin Calcium Lyophilized Powder for Injection, Teva
350 mg vial, 1 count (NDC 00703-5145-01)

Reason for the Shortage

  • Fresenius Kabi has leucovorin on shortage due to increase demand.
  • Teva has leucovorin on allocation due to increased demand.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired leucovorin calcium injection from Bedford in July 2014. West-Ward is not actively marketing leucovorin calcium injection at this time.

Available Products

Leucovorin Calcium Lyophilized Powder for Injection, Sagent
50 mg vial, 10 count (NDC 25021-0813-10)
100 mg vial, 10 count (NDC 25021-0814-30)
200 mg vial, 1 count (NDC 25021-0815-30)
350 mg vial, 1 count (NDC 25021-0816-30)
 
Leucovorin Calcium Lyophilized Powder for Injection, Teva
100 mg vial, 1 count (NDC 00703-5140-01)

Estimated Resupply Dates

  • Fresenius Kabi has leucovorin 200 mg vials on allocation. Leucovorin 500 mg vials are on back order and the company estimates a release date in late-July 2015.
  • Teva has leucovorin 350 mg vials available on allocation.

Related Shortages

Updated

July 23, June 22 and 2, April 2 and 30, March 13 and 23, February 27, January 21 and 22, 2015; December 1 and 22, November 19, October 14 and 31, September 24, August 8 and 26, July 21, June 26, May 7, 8, and 21, April 8 and 24, March 3, 14, 24 and 31, February 7, and January 15, 2014; November 8, 18, and 27, September 12, August 8 and 28, July 31, June 18, May 28, April 19, March 21, February 6 and 22, January 3 and 22, 2013; December 12 and 18, November 7, October 1, August 6 and 30, July 5, June 1, May 10, April 6, March 29, February 7 and 23, and January 1, 20, 24, and 30, 2012; December 1, November 10, September 30, August 3, 10, 24, and 31, July 22, June 29, May 20, April 19, March 30, February 3 and 11, January 5 and 20, 2011; December 16, November 3 and 8, October 14, September 2 and 17, August 18, July 7 and 20, June 6,15,22, and 30, 2010; University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement